Plasma C-Terminal Pro-Endothelin-1 and the Natriuretic Pro-Peptides NT-proBNP and MR-proANP in Very Preterm Infants with Patent Ductus Arteriosus

Publisher： Karger

E-ISSN： 1661-7819|101|2|116-124

ISSN： 1661-7800

Source： Neonatology, Vol.101, Iss.2, 2011-09, pp. : 116-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urinary NT-proBNP, NGAL, and H-FABP May Predict Hemodynamic Relevance of Patent Ductus Arteriosus in Very Low Birth Weight Infants

By  

Neonatology, Vol. 101, Iss. 4, 2012-01 ,pp. : 260-266

Karger

Access to resources Recommend Favorite

N-terminal Pro-Brain Natriuretic Peptide (NT proBNP) as a Predictive Indicator of Initial Intravenous Immunoglobulin Treatment Failure in Children With Kawasaki Disease: A Retrospective Study

By Kim So   Han Mi   Cha Sung-Ho   Jeon Yang  

Pediatric Cardiology, Vol. 34, Iss. 8, 2013-12 ,pp. : 1837-1843

Springer Publishing Company

Access to resources Recommend Favorite

N-Terminal-pro-B Type Natriuretic Peptide as a Useful Tool to Evaluate Pulmonary Hypertension and Cardiac Function in CDH Infants

By  

Neonatology, Vol. 94, Iss. 1, 2007-12 ,pp. : 22-30

Karger

Access to resources Recommend Favorite

Neurodevelopmental Outcome at 2 Years of Age according to Patent Ductus Arteriosus Management in Very Preterm Infants

By  

Neonatology, Vol. 109, Iss. 2, 2016-0 ,pp. : 139-146

Karger

Access to resources Recommend Favorite

Platelet Counts in the First Seven Days of Life and Patent Ductus Arteriosus in Preterm Very Low-Birth-Weight Infants

By  

Neonatology, Vol. 106, Iss. 3, 2014-07 ,pp. : 188-194

Karger

Access to resources Recommend Favorite